Tivicay (dolutegravir) Tablets 50 mg, 30 Tablet Bottles, Rx Only. Manufactured for: ViiV Health, TRP, NC 27709; by…
Reason Cross Contamination with Other Products: Product contains Promacta (eltrombopag).
1,709 recalls · Class III, newest first
Reason Cross Contamination with Other Products: Product contains Promacta (eltrombopag).
Reason Stability Data Does Not Support Expiry: Printed expiration date should be Nov 2013 rather than Nov 2014.
Reason Subpotent Drug: Drug potency was compromised during shipment.
Reason Presence of Precipitate: Recall is due to complaints of a white substance, confirmed as Guaifenesin, an active ingredient in the product which is…
Reason Subpotent Drug: The active ingredient, fluocinolone acetonide, was found to be subpotent during the firm's routine testing.
Reason Subpotent Drug: The active ingredient, fluocinolone acetonide, was found to be subpotent during the firm's routine testing.
Reason Subpotent Drug: The active ingredient, fluocinolone acetonide, was found to be subpotent during the firm's routine testing.
Reason Subpotent Drug: The active ingredient, fluocinolone acetonide, was found to be subpotent during the firm's routine testing.
Reason Subpotent Drug: The active ingredient, fluocinolone acetonide, was found to be subpotent during the firm's routine testing.
Reason Subpotent Drug: The active ingredient, fluocinolone acetonide, was found to be subpotent during the firm's routine testing.
Reason Subpotent Drug: The active ingredient, fluocinolone acetonide, was found to be subpotent during the firm's routine testing.
Reason Subpotent Drug: The active ingredient, fluocinolone acetonide, was found to be subpotent during the firm's routine testing.
Reason Subpotent Drug: The active ingredient, fluocinolone acetonide, was found to be subpotent during the firm's routine testing.
Reason Labeling: Label Error on Declared Strength: There is a misprint on the end flap which read 01% rather than 0.1%.
Reason Failed Impurity/degradation Specification
Reason Failed Impurities/Degradation Specifications: Product did not meet specification in total impurities at the 9-month stability station.
Reason Failed Impurities/Degradation Specifications: Product did not meet specification in total impurities at the 9-month stability station.
Reason Defective Container; some of the outer laminate foil pouches allowed in air and moisture, which could potentially decrease the effectiveness or…
Reason This recall of LIPTRUZET is being initiated due to packaging defects. Some of the outer laminate foil pouches allowed in air and moisture, which…
Reason This recall of LIPTRUZET is being initiated due to packaging defects. Some of the outer laminate foil pouches allowed in air and moisture, which…
Reason This recall of LIPTRUZET is being initiated due to packaging defects. Some of the outer laminate foil pouches allowed in air and moisture, which…
Reason Failed Impurities/Degradation Specifications: Pfizer is recalling certain lots due to out of specification results for azithromycin N-oxide degradant.
Reason Failed impurities/degradation specifications; out of specification for the known impurity 4-chlorobenzophenone.
Reason Failed Stability Testing: This product is below specification for preservative content.
Reason Failed Impurities/Degradation specifications: out-of-specification results 14 & 15 month time point